319 related articles for article (PubMed ID: 24699369)
1. MALDI-TOF MS as evolving cancer diagnostic tool: a review.
Rodrigo MA; Zitka O; Krizkova S; Moulick A; Adam V; Kizek R
J Pharm Biomed Anal; 2014 Jul; 95():245-55. PubMed ID: 24699369
[TBL] [Abstract][Full Text] [Related]
2. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
3. MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics (review).
Kriegsmann J; Kriegsmann M; Casadonte R
Int J Oncol; 2015 Mar; 46(3):893-906. PubMed ID: 25482502
[TBL] [Abstract][Full Text] [Related]
4. Matrix-assisted laser desorption/ionization imaging mass spectrometry: a promising technique for reproductive research.
Lagarrigue M; Lavigne R; Guével B; Com E; Chaurand P; Pineau C
Biol Reprod; 2012 Mar; 86(3):74. PubMed ID: 22156474
[TBL] [Abstract][Full Text] [Related]
5. Biomarker Characterization by MALDI-TOF/MS.
Cho YT; Su H; Wu WJ; Wu DC; Hou MF; Kuo CH; Shiea J
Adv Clin Chem; 2015; 69():209-54. PubMed ID: 25934363
[TBL] [Abstract][Full Text] [Related]
6. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
[TBL] [Abstract][Full Text] [Related]
7. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
Leung SM; Pitts RL
Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
[TBL] [Abstract][Full Text] [Related]
8. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome.
Hortin GL
Clin Chem; 2006 Jul; 52(7):1223-37. PubMed ID: 16644871
[TBL] [Abstract][Full Text] [Related]
9. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.
Hu S; Yu T; Xie Y; Yang Y; Li Y; Zhou X; Tsung S; Loo RR; Loo JR; Wong DT
Cancer Genomics Proteomics; 2007; 4(2):55-64. PubMed ID: 17804867
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
11. A new strategy to screen molecular imaging probe uptake in cell culture without radiolabeling using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Cheng Z; Winant RC; Gambhir SS
J Nucl Med; 2005 May; 46(5):878-86. PubMed ID: 15872363
[TBL] [Abstract][Full Text] [Related]
12. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
Solassol J; Marin P; Maudelonde T; Mangé A
Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
[TBL] [Abstract][Full Text] [Related]
13. Use of matrix-assisted laser desorption/ionisation mass spectrometry in cancer research.
Bateson H; Saleem S; Loadman PM; Sutton CW
J Pharmacol Toxicol Methods; 2011; 64(3):197-206. PubMed ID: 21549846
[TBL] [Abstract][Full Text] [Related]
14. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
[TBL] [Abstract][Full Text] [Related]
15. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
16. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
17. Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases.
Terracciano R; Preianò M; Palladino GP; Carpagnano GE; Barbaro MP; Pelaia G; Savino R; Maselli R
Proteomics; 2011 Aug; 11(16):3402-14. PubMed ID: 21751363
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic protein discovery using proteolytic peptide targeting and identification.
Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R
Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157
[TBL] [Abstract][Full Text] [Related]
19. Advances of MALDI-TOF MS in the analysis of traditional Chinese medicines.
Lu M; Cai Z
Top Curr Chem; 2013; 331():143-64. PubMed ID: 23097033
[TBL] [Abstract][Full Text] [Related]
20. MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory.
Carbonnelle E; Mesquita C; Bille E; Day N; Dauphin B; Beretti JL; Ferroni A; Gutmann L; Nassif X
Clin Biochem; 2011 Jan; 44(1):104-9. PubMed ID: 20620134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
